Dose Escalation/Reduction
Grant Drew, PharmD; Kiwon Park, PharmD; Dani Ran Castillo, MD; Lisa Hong, PharmD, BCPS
Sandra Savaya, PharmD, BCOP; Christan Mychajlonka, PharmD, BCOP; John Radosevich, PharmD; Asad Patanwala, PharmD, MPH
Alexandra Roach, MD; Hayley Heers, PharmD, BCPS, BCOP; Vishangi Dave, MD; Naveen Pemmaraju, MD; Matthew Ulrickson, MD
Ellen M. Hulterstrum, PharmD, BCOP; Carlina J. Grindeland, PharmD, BCPS, BCPPS;
Megan Czmowski, PharmD, BCOP
Kateryna Kovalenko, PharmD, BCOP; John Garrett, PharmD, MS, BCPS, BCOP, APh; Kathryn Bollin, MD; Harminder Sikand, PharmD, FCSHP, FASHP, FCCP; Leah Puglisi, MSc
Justin Liauw, PharmD; Robert Brunault, PharmD; Matt Quesenberry, MD; Brianna Bakow, MD
Kendra Jones, PharmD, MPH, BCPS; Leila Mohassel, PharmD, BCOP, BCPS; Raymund Cuevo, MD
Mark E. Jao, PharmD; Kathyrn S. Lee, PharmD, BCOP; Shannon Jeong, PharmD; Reid Nakagawa, PharmD;
Eve-Michelle Segal, PharmD, BCOP; Stacey Cohen, MD
Reduced Starting Dose of Tyrosine Kinase Inhibitors in Patients with Metastatic Renal-Cell Carcinoma
Tia M. Stitt, PharmD; Katherine M. Saunders, PharmD, BCOP; Brooke C. Rowling, PharmD Candidate; Jennifer L. Waller, PhD; Amber B. Clemmons, PharmD, BCOP, FHOPA
Christopher Sinoimeri, PharmD; Matthew Lei, PharmD, BCOP; Stephanie Monaco, PharmD, BCOP; Uvette Lou, PharmD, BCOP
- 1
- 2
Page 1 of 2
Results 1 - 10 of 18
Results 1 - 10 of 18